David Toung
Stock Analyst at Argus Research
(3.33)
# 939
Out of 4,905 analysts
123
Total ratings
62.5%
Success rate
9.65%
Average return
Main Sectors:
Stocks Rated by David Toung
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GFS GlobalFoundries | Initiates: Buy | $52 | $40.33 | +28.94% | 1 | Jul 1, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Buy | $620 → $470 | $414.75 | +13.32% | 7 | Apr 29, 2025 | |
| ELV Elevance Health | Maintains: Buy | $450 → $465 | $277.09 | +67.82% | 3 | Apr 25, 2025 | |
| UNH UnitedHealth Group | Downgrades: Hold | n/a | $282.65 | - | 8 | Apr 21, 2025 | |
| IART Integra LifeSciences Holdings | Upgrades: Buy | n/a | $11.13 | - | 2 | Mar 31, 2025 | |
| ABBV AbbVie | Upgrades: Buy | n/a | $189.26 | - | 6 | Nov 4, 2024 | |
| CAH Cardinal Health | Maintains: Buy | $115 → $125 | $159.56 | -21.66% | 9 | Sep 11, 2024 | |
| CRL Charles River Laboratories International | Downgrades: Hold | n/a | $154.48 | - | 5 | Jun 28, 2024 | |
| AMGN Amgen | Maintains: Buy | $300 → $340 | $294.76 | +15.35% | 10 | Jun 27, 2024 | |
| MCK McKesson | Maintains: Buy | $570 → $670 | $709.80 | -5.61% | 6 | Jun 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $150 | $93.19 | +60.96% | 7 | May 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $770 → $840 | $771.71 | +8.85% | 3 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $89 → $95 | $63.99 | +48.46% | 1 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $110 | $75.96 | +44.81% | 1 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $243.72 | - | 1 | Mar 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $24.47 | - | 1 | Mar 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $220.41 | - | 8 | Mar 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $285 → $310 | $389.40 | -20.39% | 2 | May 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $285 → $310 | $361.12 | -14.16% | 2 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $265 → $320 | $518.62 | -38.30% | 3 | Dec 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $135 | $123.67 | +9.16% | 4 | Jul 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $75 | $108.22 | -30.70% | 5 | Jan 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $47.36 | - | 4 | Nov 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $110 | $79.96 | +37.57% | 3 | Nov 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $165 | $89.61 | +84.13% | 6 | Aug 27, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $8.05 | - | 1 | Aug 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $110 → $123 | $52.02 | +135.49% | 3 | Jun 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $68.79 | - | 4 | Apr 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $114.25 | - | 3 | Mar 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $165 → $155 | $163.70 | -5.31% | 4 | Mar 27, 2020 |
GlobalFoundries
Jul 1, 2025
Initiates: Buy
Price Target: $52
Current: $40.33
Upside: +28.94%
Thermo Fisher Scientific
Apr 29, 2025
Maintains: Buy
Price Target: $620 → $470
Current: $414.75
Upside: +13.32%
Elevance Health
Apr 25, 2025
Maintains: Buy
Price Target: $450 → $465
Current: $277.09
Upside: +67.82%
UnitedHealth Group
Apr 21, 2025
Downgrades: Hold
Price Target: n/a
Current: $282.65
Upside: -
Integra LifeSciences Holdings
Mar 31, 2025
Upgrades: Buy
Price Target: n/a
Current: $11.13
Upside: -
AbbVie
Nov 4, 2024
Upgrades: Buy
Price Target: n/a
Current: $189.26
Upside: -
Cardinal Health
Sep 11, 2024
Maintains: Buy
Price Target: $115 → $125
Current: $159.56
Upside: -21.66%
Charles River Laboratories International
Jun 28, 2024
Downgrades: Hold
Price Target: n/a
Current: $154.48
Upside: -
Amgen
Jun 27, 2024
Maintains: Buy
Price Target: $300 → $340
Current: $294.76
Upside: +15.35%
McKesson
Jun 24, 2024
Maintains: Buy
Price Target: $570 → $670
Current: $709.80
Upside: -5.61%
May 21, 2024
Upgrades: Buy
Price Target: $150
Current: $93.19
Upside: +60.96%
May 14, 2024
Maintains: Buy
Price Target: $770 → $840
Current: $771.71
Upside: +8.85%
May 9, 2024
Maintains: Buy
Price Target: $89 → $95
Current: $63.99
Upside: +48.46%
Apr 1, 2024
Maintains: Buy
Price Target: $80 → $110
Current: $75.96
Upside: +44.81%
Mar 25, 2024
Upgrades: Buy
Price Target: n/a
Current: $243.72
Upside: -
Mar 22, 2024
Downgrades: Hold
Price Target: n/a
Current: $24.47
Upside: -
Mar 13, 2024
Downgrades: Hold
Price Target: n/a
Current: $220.41
Upside: -
May 25, 2023
Maintains: Buy
Price Target: $285 → $310
Current: $389.40
Upside: -20.39%
May 10, 2023
Maintains: Buy
Price Target: $285 → $310
Current: $361.12
Upside: -14.16%
Dec 22, 2022
Maintains: Buy
Price Target: $265 → $320
Current: $518.62
Upside: -38.30%
Jul 28, 2022
Maintains: Buy
Price Target: $150 → $135
Current: $123.67
Upside: +9.16%
Jan 28, 2022
Upgrades: Buy
Price Target: $75
Current: $108.22
Upside: -30.70%
Nov 1, 2021
Downgrades: Hold
Price Target: n/a
Current: $47.36
Upside: -
Nov 1, 2021
Upgrades: Buy
Price Target: $110
Current: $79.96
Upside: +37.57%
Aug 27, 2021
Maintains: Buy
Price Target: $150 → $165
Current: $89.61
Upside: +84.13%
Aug 2, 2021
Downgrades: Hold
Price Target: n/a
Current: $8.05
Upside: -
Jun 18, 2021
Maintains: Buy
Price Target: $110 → $123
Current: $52.02
Upside: +135.49%
Apr 12, 2021
Downgrades: Hold
Price Target: n/a
Current: $68.79
Upside: -
Mar 10, 2021
Downgrades: Hold
Price Target: n/a
Current: $114.25
Upside: -
Mar 27, 2020
Reiterates: Buy
Price Target: $165 → $155
Current: $163.70
Upside: -5.31%